Antiparasitic Wins FDA Approval for High-Risk Neuroblastoma ...Middle East

Medscape - News
The FDA approved eflornithine to treat this rare cancer in adult and pediatric patients. The drug has also been approved to reduce excessive facial hair growth and to treat sleeping sickness. Medscape Medical News

Hence then, the article about antiparasitic wins fda approval for high risk neuroblastoma was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Antiparasitic Wins FDA Approval for High-Risk Neuroblastoma )

Apple Storegoogle play

Last updated :

Also on site :